MDM2 proliferative targets include the activation of E2 F1 transcriptional activity and suppression of tumor suppressive effects of Rb through binding to Rb and inhibiting the function of Rb-E2 F repressor (Wu and Wu 2021). The gene discussed is RB1; the disease is neoplasm.